中文 | English
Return
Total: 40 , 1/4
Show Home Prev Next End page: GO
Author:( Ke-feng DOU)

3.Development of SMART Technology and It’s Application

Wei-Hui LIU ; Ke-Feng DOU ;

China Biotechnology 2006;0(06):-

4.Comparison of the Efficacy for Diabetic Mice Xenotransplanted with Two Types of Microencapsulated Rat Islets

Qi XU ; Ke-feng DOU ; Zhen-shun SONG ; Fuqin ZHANG

Chinese Journal of Rehabilitation Theory and Practice 2006;12(5):383-384

6.Application of two bacteria colony-PCR methods in the screening of phage antibody library

Guo-Zhu XUE ; Ke-Feng DOU ; Yong-Gang LV ; Li-Bo YAO ;

Journal of Medical Postgraduates 2003;0(12):-

7.Protective effects of tumor necrosis factor-α antibody on pancreatic encephalopathy in rats

Yan-ling YANG ; Xiao-ping XU ; Ke-feng DOU ; Kaizong LI

Chinese Journal of Rehabilitation Theory and Practice 2004;10(3):165-166

8.Effect of hemodialysis with plasma-based dialysate plus high volume hemofiltration on plasma cytokines in patients with liver failure

Wei CHEN ; Hong-Bao LIU ; Zhen-Jiang LI ; Ke-Feng DOU ; Zhen-Shun SONG ; Yue-Qing XU ; Han-Min WANG ;

Chinese Journal of Nephrology 2005;0(12):-

9.Compliance on hand-hygiene among healthcare providers working at secondary and tertiary general hospitals in Chengdu

Ke HAN ; Feng-Man DOU ; Li-Jie ZHANG ; Bao-Ping ZHU

Chinese Journal of Epidemiology 2011;32(11):1139-1142

10.The expression and significance of decorin in chronic rejection of liver transplantion

Jianying SHANGGUAN ; Zhen-Yu TI ; Xiao LI ; Xiao-Jun HU ; Fu-Qin ZHANG ; Zhao-Sheng YONG ; Ke-Feng DOU ; Kai-Shan TAO ;

International Journal of Surgery 2010;37(11):739-742,封3

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 40 , 1/4 Show Home Prev Next End page: GO